IntrinsicIntrinsic
← Scroll for more →

Financial Statements — AVTX

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents85.3824.9926.9642.29125.0581.8693.43110.1810.186.3116.6916.9411.2538.4771.5140.4438.29
Short-term Investments314.8957.0184.6570.97--------------------------
Accounts Receivable------------------0.04--------------
Inventory----------------0.000.020.020.020.020.030.020.020.00
Total Current Assets407.9388.83113.85115.19126.9486.1595.89111.2112.667.5219.2519.4515.0243.6677.0147.3646.10
Goodwill10.5010.5010.5010.5010.5010.5010.5010.5014.4114.4114.4114.4114.4114.4114.4114.4114.41
Intangible Assets----------------------0.000.000.000.300.731.16
Total Non-current Assets*82.8511.0611.2511.4011.5812.3112.4112.5216.6116.7216.9817.1017.2018.2418.3516.7217.25
Total Assets490.7899.89125.10126.58138.5298.46108.31123.7329.2724.2436.2436.5532.2261.9095.3664.0863.35
Accounts Payable3.350.360.472.370.681.810.650.920.790.755.571.452.163.763.573.9711.91
Total Current Liabilities21.1311.607.979.265.6260.6796.40215.706.0122.4523.2518.1515.4017.8919.0421.6726.36
Total Non-current Liabilities*20.9919.9725.5812.7510.2915.0514.069.118.578.7519.2620.4322.7837.6636.0120.823.83
Total Liabilities42.1231.5733.5522.0115.9175.72110.46224.8114.5831.2042.5038.5838.1755.5655.0542.5030.19
Retained Earnings(504.51)(468.15)(434.80)(404.18)(383.41)(334.92)(357.96)(456.42)(326.97)(321.74)(313.78)(294.01)(297.20)(284.22)(242.97)(225.57)(208.47)
Total Stockholder Equity448.6668.3291.55104.57122.6221.08(13.61)(112.54)14.70(6.97)(6.27)(2.03)(5.95)6.3440.3121.5933.16
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue----0.060.000.00--0.190.250.000.000.570.240.640.480.9014.951.031.170.221.35
Cost of Revenue--------0.00----(0.71)0.34(0.08)(0.22)0.250.710.550.620.531.570.720.420.91
Gross Profit--------(0.26)----0.96(0.34)0.080.79(0.01)(0.06)(0.08)0.2814.42(0.53)0.45(0.20)0.44
Research & Development----------------------------------------
Selling, General & Admin8.106.856.545.585.245.555.234.294.533.192.682.492.432.71--3.282.789.765.125.19
Total Operating Expenses--------42.08----13.829.2332.858.453.747.098.729.1310.3311.2921.3117.7616.91
Operating Income(31.52)(20.90)(19.74)(19.20)(19.32)(14.67)(13.31)(12.86)(9.57)(32.77)(7.66)(3.75)(7.15)(8.79)(8.85)4.10(11.83)(20.85)(17.96)(16.46)
Pretax Income(36.34)(19.62)(13.59)(30.61)(20.75)(13.14)(35.22)23.0298.47(121.28)(8.18)(5.22)(8.19)(9.95)--3.20(12.98)(22.04)--(17.46)
Tax Provision0.020.010.130.010.020.010.11(0.01)0.010.01(0.01)0.010.010.010.010.010.010.01(0.02)0.01
Net Income(36.36)(19.63)(13.72)(30.62)(20.76)(13.15)(35.34)23.0498.46(121.29)(8.17)(5.23)(8.19)(9.95)(9.81)3.19(12.99)(22.05)(19.20)(17.39)
Basic EPS(0.83)(0.98)(0.48)(2.19)(1.92)(1.25)127.870.984.21(141.00)(112.45)(0.11)(0.59)(0.85)(1.04)----------
Diluted EPS(0.83)(0.98)(0.48)(2.19)(1.92)(1.25)136.99(2.83)(14.07)(141.00)(112.45)(0.11)(0.59)(0.85)(1.04)----------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(19.99)(17.69)(14.25)(16.36)(11.39)(9.46)(15.04)(11.53)(16.28)(6.20)(2.77)(6.84)(11.03)(10.05)(3.94)5.73(12.47)(16.07)(17.10)(16.29)
Capital Expenditures------------0.000.000.000.000.000.000.000.160.000.040.060.000.010.08
Free Cash Flow*------------(15.04)(11.53)(16.28)(6.20)(2.77)(6.84)(11.03)(10.21)(3.94)5.69(12.53)(16.07)(17.11)(16.37)
Investing Cash Flow(329.92)25.512.40(13.26)(70.86)0.000.000.000.000.360.000.000.00(0.13)0.00(0.04)(0.06)0.00(0.01)(0.08)
Financing Cash Flow410.211.400.6914.37(0.47)0.0067.710.00(0.47)108.610.0010.700.6013.750.080.00(14.78)0.000.0847.64
← Scroll for more columns →

* Derived from reported values